Search the hub

This case study is one in a set of NHS England patient safety ‘how we acted on patient safety issues you recorded’ case studies which show the direct action taken in response to patient safety events recorded by organisations, staff and the public, and how their actions support the NHS to protect patients from harm. The National Patient Safety Team identified an incident where the incorrect treatment was given to a patient when the wrong point of care (POC) test strip was used. This led to a ketone result being interpreted as a blood glucose result. Mistaking a ketone value for a blood glucose value can obscure detection of dangerously high levels of ketones in the blood, ultimately leading to a harmful condition called diabetic ketoacidosis (DKA). A review of incident data revealed other examples of wrong strip selection due to their visual similarity, local labelling, and storage issues. The review also showed that some staff didn’t realise that certain POC devices can be used with multiple different strips. Despite the strips meeting design and packaging criteria to prevent such errors, it was clear the potential for errors exists. A request was made to include insight from our review into educational material through the National Association of Medical Device Educators and Trainers (NAMDET) and POC leads. Resources for the management of hospital POC systems also now exist to support the implementation, management, and use of POC devices in clinical practice.

The Covid-19 pandemic, which rapidly escalated into a global crisis that impacted millions of lives and disrupted economies around the world, was a wake-up call for the management of infectious disease outbreaks. Dr Stella Chungong and Dr Landry Ndriko Mayigane work for the Health Security Preparedness Department in the World Health Organization’s Health Emergencies Programme. In this article, they encourage countries to implement early action reviews (EARs) of disease outbreaks. EARs help countries assess their vigilance, planning and responsiveness, and could help countries be better prepared during outbreaks.  The guidelines detail three time-based metrics, named 7-1-7, which offer a simple, structured approach to outbreak management: 7 Days to Detect, which measures how quickly the country can detect a suspected disease outbreak, with the aim being detection within 7 days. 1 Day to Notify, which measures the time taken to notify relevant public health authorities and stakeholders, with the aim being notification within 1 day. This goal is not new; it is consistent with the International Health Regulations (2005) that require countries to notify the relevant authorities within 24 hours of detecting a disease outbreak. 7 Days to Respond measures how quickly the country can establish a response to the outbreak, the aim being the instigation of effective response actions within 7 days.

Cancer Research UK has set out how the next UK Government could dramatically improve cancer outcomes and prevent 20,000 cancer deaths a year by 2040.  'Longer better lives: A manifesto for cancer research and care' has been developed with the insights of cancer patients and experts from across health, life sciences, government and academic sectors.   The charity said that huge strides have been made in beating cancer – with survival in the UK doubling over the last 50 years.  But it warned that with NHS cancer services in crisis and around half a million new cancer cases each year expected by 2040 – this hard-won progress is at risk of stalling.    With the UK lagging behind comparable countries when it comes to cancer survival, the charity is calling on all political parties to make cancer a top priority in their party manifestos.  In the Manifesto, the charity sets out the following five missions for the Government to follow to dramatically improve cancer outcomes. They are: 1. Rebuild the UK’s global position in biomedical research. The UK Government should set an ambition in its first 100 days to lead the G7 in research intensity, increase government investment and make the UK an attractive destination for scientists and clinicians worldwide. 2. Prevent thousands more cancer cases. The UK Government has a once in a generation opportunity to tackle one of the biggest health issues facing the country – smoking. Around 500,000 hospital admissions every year in England are attributable to smoking – equivalent to one person being admitted every minute. The UK Government should urgently progress laws to increase the age of sale of tobacco products. If these measures help achieve a smoke free England by 2030, it could prevent around 18,200 cancer cases in the country by 2040. 3. Diagnose cancers earlier and reduce inequalities. Almost half of cancers in England are diagnosed at a late stage, and around 1 in 5 cancer patients are diagnosed via emergency routes. Earlier cancer diagnosis saves lives, and we are calling on the UK Government to implement measures to reduce late-stage diagnosis in England. The UK Government should transform and optimise cancer screening programmes and accelerate the roll-out of the lung cancer screening programme in England. Cancer Research UK is also calling on the UK Government to address variation in treatment across different geographical areas and reduce inequalities in early diagnosis in England through targeted action plans. 4. Bring tests, treatments and innovations to patients more quickly. Despite the tireless work of staff within the NHS, patients continue to wait far too long for vital tests and treatment. While there is huge potential for innovation in the NHS, change must be backed by long-term funding for staff, essential kit and facilities. The UK Government should set out a 10-year cancer-specific workforce plan to address the chronic staff shortages in cancer services. The UK Government should eliminate the £10.2 billion NHS maintenance deficit by 2030 and commit to rolling ringfenced capital investment for cancer. 5. Build a national movement to beat cancer, together. The current system is fragmented. In England, responsibility for cancer research and care is spread across NHS England, at least 5 government departments and multiple agencies. Cancer Research UK thinks that the best opportunities for improving cancer outcomes need those responsible for research, innovation, NHS services and public health from across government to coordinate their actions, ensuring we accelerate research, the adoption of innovation and reduce inequalities for everyone affected by cancer. A new National Cancer Council for England, accountable to the Prime Minister, should be set up to drive cross-government action on cancer and deliver a 10-year cancer strategy for England.